Combining pharmacophore and protein modeling to predict CYP450 inhibitors and substrates

Fragment Coverage: Unified Visualization and Quantitative Assessment of MS/MS Fragmentation Supports Metabolite Identification in Macromolecule Drug Metabolism Studies.

Rapid communications in mass spectrometry : RCM·2026

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Journal of personalized medicine·2026

Helmkit: fast and robust conversion of HELM notation to atomistic representations for large-scale macromolecular informatics.

Journal of cheminformatics·2026

Machine Learning-Assisted False Positive Detection in Metabolite Identification Workflows.

Analytical chemistry·2025

Prediction of peptide cleavage sites using protein language models and graph neural networks.

Scientific reports·2025

An automated software-assisted approach for exploring metabolic susceptibility and degradation products in macromolecules using high-resolution mass spectrometry.

PloS one·2025

Mechanistic insights on HDAC6 ZnF UBP-Tau interaction through biophysical and computational approaches.

Methods in enzymology·2026

Methodological frameworks to probe histone acetylation-driven circuit plasticity in SYNGAP1-associated neurodevelopmental disorders.

Methods in enzymology·2026

Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6.

Methods in enzymology·2026

Protocols for in vitro analysis of liquid-liquid phase separation of proteins.

Methods in enzymology·2026

Experimental approaches to study histone deacetylation in Caenorhabditis elegans.

Methods in enzymology·2026

Histone deacetylases: From acetylation homeostasis to oncogenic and neurodegenerative disorders.

Methods in enzymology·2026

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

Pharmacology research & perspectives·2026

In Silico Evaluation of Annonaceous Acetogenins as Potential HER2 and MELK Inhibitors for Targeted Cancer Therapy.

Anti-cancer agents in medicinal chemistry·2026

Computational Discovery of Phytochemicals Targeting InhA of Mycobacterium tuberculosis: Insights from Molecular Docking, MMGBSA, ADME Profiling, and Molecular Dynamics Simulations.

Current computer-aided drug design·2026

Chalcones as a Platform for the Development of Novel Antiviral Agents: A Review.

Mini reviews in medicinal chemistry·2026

Design of Quinazoline Dual Inhibitors Targeting Focal Adhesion Kinase and Polo-like Kinase 1 for Metastatic Cancers: QSAR, Pharmacophore Modelling, and Molecular Docking Approaches.

Current pharmaceutical design·2026

In-silico Identification of Cyclic Peptide Inhibitors for A42r Profilin-like Protein from Monkeypox Virus.

Current drug targets·2026

Related Experiment Videos

Combining pharmacophore and protein modeling to predict CYP450 inhibitors and substrates

Related Concept Videos

Fragment Coverage: Unified Visualization and Quantitative Assessment of MS/MS Fragmentation Supports Metabolite Identification in Macromolecule Drug Metabolism Studies.

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Helmkit: fast and robust conversion of HELM notation to atomistic representations for large-scale macromolecular informatics.

Machine Learning-Assisted False Positive Detection in Metabolite Identification Workflows.

Prediction of peptide cleavage sites using protein language models and graph neural networks.

An automated software-assisted approach for exploring metabolic susceptibility and degradation products in macromolecules using high-resolution mass spectrometry.

Mechanistic insights on HDAC6 ZnF UBP-Tau interaction through biophysical and computational approaches.

Methodological frameworks to probe histone acetylation-driven circuit plasticity in SYNGAP1-associated neurodevelopmental disorders.

Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6.

Protocols for in vitro analysis of liquid-liquid phase separation of proteins.

Experimental approaches to study histone deacetylation in Caenorhabditis elegans.

Histone deacetylases: From acetylation homeostasis to oncogenic and neurodegenerative disorders.

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

In Silico Evaluation of Annonaceous Acetogenins as Potential HER2 and MELK Inhibitors for Targeted Cancer Therapy.

Computational Discovery of Phytochemicals Targeting InhA of Mycobacterium tuberculosis: Insights from Molecular Docking, MMGBSA, ADME Profiling, and Molecular Dynamics Simulations.

Chalcones as a Platform for the Development of Novel Antiviral Agents: A Review.

Design of Quinazoline Dual Inhibitors Targeting Focal Adhesion Kinase and Polo-like Kinase 1 for Metastatic Cancers: QSAR, Pharmacophore Modelling, and Molecular Docking Approaches.

In-silico Identification of Cyclic Peptide Inhibitors for A42r Profilin-like Protein from Monkeypox Virus.

Related Experiment Videos

Combining pharmacophore and protein modeling to predict CYP450 inhibitors and substrates

Related Concept Videos

Related Articles